SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 15.13
-1.50 (-9.02%)
At close: Dec 5, 2025
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 39.14 million as of December 5, 2025. Its market cap has increased by 7.93% in one year.
Market Cap
39.14M
Enterprise Value
35.35M
Revenue
4.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.13
Market Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 39.14M, an increase of 148.84%. That is a compound annual growth rate of 11.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 39.14M | -7.38% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | 36.63M | 97.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.35B |
| GSK plc | 73.57B |
| Haleon | 32.16B |
| Smith & Nephew | 10.46B |
| Convatec Group | 4.46B |
| Hikma Pharmaceuticals | 3.50B |
| HUTCHMED (China) | 1.85B |
| Genus | 1.73B |